Login
Home
Charts
Search
Watchlist
Products

Hannah Joseph Hospital Ltd

HANNAH·BSE
114.50+3.15%Tue, 22 Sept '26 12:16

Hannah Joseph Hospital Ltd

HANNAH
BSE
114.50
+3.15%
|Tue, 22 Sept '26 12:16
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
260Cr
Close
Close Price
114.50
Industry
Industry
Hospitals/Medical Services
PE
Price To Earnings
33.38
PS
Price To Sales
2.82
Revenue
Revenue
92Cr
Rev Gr TTM
Revenue Growth TTM
18.72%
PAT Gr TTM
PAT Growth TTM
55.08%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
41374350
Growth YoY
Revenue Growth YoY%
5.033.8
Expenses
ExpensesCr
29283136
Operating Profit
Operating ProfitCr
1191213
OPM
OPM%
27.925.327.627.1
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
2221
Depreciation
DepreciationCr
4433
PBT
PBTCr
1081012
Tax
TaxCr
2123
PAT
PATCr
4356
Growth YoY
PAT Growth YoY%
25.294.2
NPM
NPM%
10.18.412.012.2
EPS
EPS
0.00.00.03.4
QuarterSep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
41374350
Growth YoY
Revenue Growth YoY%
5.033.8
Expenses
ExpensesCr
29283136
Operating Profit
Operating ProfitCr
1191213
OPM
OPM%
27.925.327.627.1
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
2221
Depreciation
DepreciationCr
4433
PBT
PBTCr
1081012
Tax
TaxCr
2123
PAT
PATCr
4356
Growth YoY
PAT Growth YoY%
25.294.2
NPM
NPM%
10.18.412.012.2
EPS
EPS
0.00.00.03.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
365855637892
Growth
Revenue Growth%
63.3-6.016.122.318.7
Expenses
ExpensesCr
284038455767
Operating Profit
Operating ProfitCr
71817182125
OPM
OPM%
20.631.430.328.626.727.4
Other Income
Other IncomeCr
200001
Interest Expense
Interest ExpenseCr
576533
Depreciation
DepreciationCr
7119877
PBT
PBTCr
-20151016
Tax
TaxCr
000135
PAT
PATCr
-2014711
Growth
PAT Growth%
113.8198.6302.477.355.1
NPM
NPM%
-6.90.61.96.49.312.2
EPS
EPS
-13.90.90.62.44.36.3
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
365855637892
Growth
Revenue Growth%
63.3-6.016.122.318.7
Expenses
ExpensesCr
284038455767
Operating Profit
Operating ProfitCr
71817182125
OPM
OPM%
20.631.430.328.626.727.4
Other Income
Other IncomeCr
200001
Interest Expense
Interest ExpenseCr
576533
Depreciation
DepreciationCr
7119877
PBT
PBTCr
-20151016
Tax
TaxCr
000135
PAT
PATCr
-2014711
Growth
PAT Growth%
113.8198.6302.477.355.1
NPM
NPM%
-6.90.61.96.49.312.2
EPS
EPS
-13.90.90.62.44.36.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
21116171723
Reserves
ReservesCr
231418293575
Current Liabilities
Current LiabilitiesCr
11920131511
Non Current Liabilities
Non Current LiabilitiesCr
585337313025
Total Liabilities
Total LiabilitiesCr
9486929097133
Current Assets
Current AssetsCr
4515202050
Non Current Assets
Non Current AssetsCr
908177707683
Total Assets
Total AssetsCr
9486929097133
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
21116171723
Reserves
ReservesCr
231418293575
Current Liabilities
Current LiabilitiesCr
11920131511
Non Current Liabilities
Non Current LiabilitiesCr
585337313025
Total Liabilities
Total LiabilitiesCr
9486929097133
Current Assets
Current AssetsCr
4515202050
Non Current Assets
Non Current AssetsCr
908177707683
Total Assets
Total AssetsCr
9486929097133

Cash Flow

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7152181921
Investing Cash Flow
Investing Cash FlowCr
-80-5-4-14-14
Financing Cash Flow
Financing Cash FlowCr
2-14-10-3-325
Net Cash Flow
Net Cash FlowCr
1152332
Free Cash Flow
Free Cash FlowCr
-115178811
CFO To PAT
CFO To PAT%
-266.94,490.42,059.6197.5269.4184.9
CFO To EBITDA
CFO To EBITDA%
89.283.4126.044.393.982.1
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
7152181921
Investing Cash Flow
Investing Cash FlowCr
-80-5-4-14-14
Financing Cash Flow
Financing Cash FlowCr
2-14-10-3-325
Net Cash Flow
Net Cash FlowCr
1152332
Free Cash Flow
Free Cash FlowCr
-115178811
CFO To PAT
CFO To PAT%
-266.94,490.42,059.6197.5269.4184.9
CFO To EBITDA
CFO To EBITDA%
89.283.4126.044.393.982.1

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
158260
Price To Earnings
Price To Earnings
14.133.4
Price To Sales
Price To Sales
1.72.8
Price To Book
Price To Book
1.62.7
EV To EBITDA
EV To EBITDA
5.69.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.859.476.172.355.556.856.8
OPM
OPM%
20.631.430.328.626.727.427.4
NPM
NPM%
-6.90.61.96.49.312.212.2
ROCE
ROCE%
2.99.89.613.115.615.315.3
ROE
ROE%
-10.01.42.98.913.911.511.5
ROA
ROA%
-2.60.41.14.57.58.48.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
158260
Price To Earnings
Price To Earnings
14.133.4
Price To Sales
Price To Sales
1.72.8
Price To Book
Price To Book
1.62.7
EV To EBITDA
EV To EBITDA
5.69.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
56.859.476.172.355.556.856.8
OPM
OPM%
20.631.430.328.626.727.427.4
NPM
NPM%
-6.90.61.96.49.312.212.2
ROCE
ROCE%
2.99.89.613.115.615.315.3
ROE
ROE%
-10.01.42.98.913.911.511.5
ROA
ROA%
-2.60.41.14.57.58.48.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Hannah Joseph Hospital is a single-facility hospital in Madurai built entirely around the brain - it began in 2008 as a neurosurgery and trauma centre, grew into a comprehensive neurological institute by adding its own neuroradiology department, and now layers other specialties on top of that core, using the same approach of bringing advanced diagnostics and surgical technology under one roof. The hospital was founded and is still led by a neurosurgeon and a psychiatrist, listed on the BSE SME platform in February 2026, and draws patients from across South Tamil Nadu and from Sri Lanka, Malaysia, Singapore and the Middle East. Everything it does follows a single logic: build a centre of excellence in a complex specialty where the barriers to entry are high, then extend that reputation into adjacent services that the same patients need. # Business segments A single-engine business - a tertiary-care hospital where neurosciences and trauma form the clinical anchor, and pharmacy and dietary services are ancillaries delivered on-site to the same patients. ## 1. Hospital services: a neuroscience institute that also treats everything else **The hospital earns by performing complex brain and spine surgeries, treating trauma patients, and running a full neurology and psychiatry practice - then captures the diagnostic scans, medicines and meals those patients need during their stay.** - **Neurosurgery is the anchor** - in FY26 the hospital performed 402 neurosurgery cases and 236 orthopaedic/trauma cases, meaning roughly two out of every three operations involved the brain or spine. It uses a BrainLab Navigation System with AI-powered fibre tracking, introduced in 2024 as the first such system in South Asia or India, which lets surgeons see critical neural pathways in real time during an operation. - **Trauma and orthopaedics feed off the same emergency infrastructure** - the remaining 236 surgeries were orthopaedic and trauma cases, and in 2026 the hospital launched a 24/7 emergency medical service at Madurai Airport, so accident victims can reach the operating theatre faster. - **Diagnostics are done in-house, not sent out** - the hospital has its own neuroradiology department with MRI and CT, a NABL-accredited lab for pathology and molecular diagnostics, and a pharmacy that dispenses medicines on-site, which together generated 28% of revenue from pharmacy sales and a further share from diagnostic charges bundled into inpatient bills. This keeps the full value of each patient episode inside the building. - **Paid per service, not per patient** - revenue is recognised as each service is delivered: inpatient and outpatient care over time, pharmacy and consumable sales at the point of dispensing, and insurance claims based on what is expected to be realised after historical settlement patterns. The hospital has tie-ups with 34 insurers, so a large share of patients pay through third-party claims rather than out of pocket. - **Oncology is the next layer** - the hospital already offers chemotherapy, targeted therapy, immunotherapy support and neuro-oncology surgery, and is building a dedicated radiation oncology centre on adjacent land acquired during FY26, funded by IPO proceeds. This extends the same model: take a high-complexity specialty, put the diagnostics and treatment under one roof, and capture the full care cycle. # Group structure and partners **A founder-led, family-run public company with no subsidiaries, no joint ventures and no foreign operations - the entire business is one hospital in Madurai.** - **Promoter-controlled** - Dr. Moses Joseph Arunkumar, the Managing Director and a neurosurgeon with over 25 years of experience, held 69.21% of the equity as of March 2026; his spouse Dr. Fenn Kavitha Fenn Arunkumar serves as Whole-time Director, and their daughter and son sit on the board as Non-Executive Directors alongside four Independent Directors. - **No external entanglements** - the company has no subsidiaries, associates or joint ventures, has incurred foreign currency expenditure, and has never accepted public deposits or dealt in crypto. - **Key management is lean** - the senior team consists of the Managing Director, the Whole-time Director, a Chief Financial Officer and a Company Secretary.

Documents — Hannah Joseph Hospital Ltd

  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/p761kierj7e71jiyjfrz1df6.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/sdoi9yq9bw0zl2aoiqw2uaxk.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/m329ga1179slgrwxbu36eftd.pdf